IL140044A0 - Compounds with growth hormone releasing properties - Google Patents

Compounds with growth hormone releasing properties

Info

Publication number
IL140044A0
IL140044A0 IL14004499A IL14004499A IL140044A0 IL 140044 A0 IL140044 A0 IL 140044A0 IL 14004499 A IL14004499 A IL 14004499A IL 14004499 A IL14004499 A IL 14004499A IL 140044 A0 IL140044 A0 IL 140044A0
Authority
IL
Israel
Prior art keywords
growth hormone
compounds
hormone releasing
releasing properties
properties
Prior art date
Application number
IL14004499A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL140044A0 publication Critical patent/IL140044A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL14004499A 1998-06-30 1999-06-29 Compounds with growth hormone releasing properties IL140044A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199800857 1998-06-30
DKPA199801440 1998-11-09
PCT/DK1999/000368 WO2000001726A1 (fr) 1998-06-30 1999-06-29 Composes a proprietes de liberation de l'hormone de croissance

Publications (1)

Publication Number Publication Date
IL140044A0 true IL140044A0 (en) 2002-02-10

Family

ID=26064788

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14004499A IL140044A0 (en) 1998-06-30 1999-06-29 Compounds with growth hormone releasing properties

Country Status (20)

Country Link
EP (1) EP1100824B1 (fr)
JP (1) JP4511040B2 (fr)
KR (1) KR100907638B1 (fr)
CN (1) CN1304424C (fr)
AT (1) ATE500269T1 (fr)
AU (1) AU771644B2 (fr)
BR (1) BRPI9911756B1 (fr)
CA (1) CA2334315C (fr)
CY (1) CY1111509T1 (fr)
CZ (1) CZ299648B6 (fr)
DE (1) DE69943239D1 (fr)
DK (1) DK1100824T3 (fr)
HU (1) HUP0102460A3 (fr)
IL (1) IL140044A0 (fr)
NO (1) NO331351B1 (fr)
PL (1) PL199853B1 (fr)
PT (1) PT1100824E (fr)
RU (1) RU2298547C2 (fr)
TW (1) TW593337B (fr)
WO (1) WO2000001726A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462200A1 (fr) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetiques de metallopeptides biologiquement actifs
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
EP1735055A1 (fr) * 2004-03-30 2006-12-27 Sapphire Therapeutics, Inc. Procede de reduction de la proteine c-reactive a l'aide de secretagogues de l'hormone de croissance
ES2388501T3 (es) 2004-08-12 2012-10-16 Helsinn Healthcare S.A. Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Ｂｉｒドメイン結合化合物
BRPI0617751A2 (pt) 2005-10-25 2011-08-02 Aegera Therapeutics Inc compostos de ligação do domìnio iap bir
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法
CN107382827B (zh) * 2017-04-14 2021-01-01 江苏普莱医药生物技术有限公司 氨基酸衍生物或其药学上可接受的盐及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282166B6 (sk) * 1992-12-11 2001-11-06 Merck & Co., Inc. Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom
AU711104B2 (en) * 1995-06-22 1999-10-07 Novo Nordisk A/S Compounds with growth hormone releasing properties
EP0869974B1 (fr) * 1995-12-22 2009-03-04 Novo Nordisk A/S Composes avec des proprietes de liberation de l'hormone de croissance
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
EP1005484A1 (fr) * 1997-06-20 2000-06-07 Novo Nordisk A/S Composes ayant des proprietes de liberation de l'hormone de croissance

Also Published As

Publication number Publication date
CN1304424C (zh) 2007-03-14
EP1100824B1 (fr) 2011-03-02
CY1111509T1 (el) 2015-08-05
CZ20004565A3 (en) 2001-06-13
JP4511040B2 (ja) 2010-07-28
PL199853B1 (pl) 2008-11-28
ATE500269T1 (de) 2011-03-15
HUP0102460A3 (en) 2001-12-28
CA2334315C (fr) 2011-07-26
HUP0102460A2 (hu) 2001-11-28
PT1100824E (pt) 2011-06-16
CZ299648B6 (cs) 2008-10-01
BRPI9911756B1 (pt) 2016-06-14
DE69943239D1 (de) 2011-04-14
JP2002519436A (ja) 2002-07-02
PL345204A1 (en) 2001-12-03
CA2334315A1 (fr) 2000-01-13
CN1307588A (zh) 2001-08-08
NO331351B1 (no) 2011-12-05
BR9911756A (pt) 2001-04-03
DK1100824T3 (da) 2011-06-20
NO20006699D0 (no) 2000-12-29
EP1100824A1 (fr) 2001-05-23
KR20010053310A (ko) 2001-06-25
RU2298547C2 (ru) 2007-05-10
AU4603899A (en) 2000-01-24
WO2000001726A1 (fr) 2000-01-13
AU771644B2 (en) 2004-04-01
NO20006699L (no) 2001-02-28
KR100907638B1 (ko) 2009-07-14
TW593337B (en) 2004-06-21

Similar Documents

Publication Publication Date Title
IL139090A0 (en) Compounds with growth hormone releasing properties
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
MY117032A (en) A novel compound form.
DE69905170D1 (en) Thiazolopyrimidinderivate
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
YU13301A (sh) Muskarinski agonisti i antagonisti
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
IL140044A0 (en) Compounds with growth hormone releasing properties
BG101401A (en) Cisaspide extended release oral compositions
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
PL352104A1 (en) Oral composition containing perlite
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
PL347433A1 (en) Compounds with growth hormone releasing properties
IL137007A0 (en) Compounds with growth hormone releasing properties
HUP0200637A3 (en) Compounds, compositions, and their use for stimulating neuronal growth and elongation
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees